Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MITF | O75030 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.47 |
| ▸ | HTR7 | P34969 | 4/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | HTR6 | P50406 | 1/20 | 0.43 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KRAS | P01116 | 1/20 | 0.39 |
| ▸ | SOS1 | Q07889 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21798457 | 1.00 | ALDH1A1 (0.52) | ALDH1A1KMT2AHTTLMNAMITF | |
| SCHEMBL3038409 | 0.83 | HTT (0.49) | ALDH1A1KMT2AHTTLMNAMAPT | |
| SCHEMBL3031567 | 0.80 | SCN8A (0.47) | ALDH1A1KMT2AHTTLMNAMITF | |
| SCHEMBL22766709 | 0.79 | ALDH1A1 (0.48) | ALDH1A1KMT2AHTTLMNAMITF | |
| SCHEMBL19954150 | 0.77 | ALDH1A1 (0.51) | ALDH1A1KMT2AHTTLMNAMITF | |
| SCHEMBL13137650 | 0.77 | ALDH1A1 (0.51) | ALDH1A1KMT2AHTTLMNAMITF | |
| SCHEMBL4296721 | 0.76 | ALDH1A1 (0.49) | ALDH1A1KMT2AHTTLMNAMITF | |
| SCHEMBL16680212 | 0.75 | ALDH1A1 (0.45) | ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL16680210 | 0.75 | ALDH1A1 (0.45) | ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL6009922 | 0.73 | HTT (0.43) | ALDH1A1KMT2AHTTLMNAMITF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10738064-B2 | Chiral α-amino tertiary boronic esters | PURDUE RESEARCH FOUNDATION (US) | 2020-08-11 | — | — | US | disclosed |
| US-20200079799-A1 | Novel Chiral Alfa-Amino Tertiary Boronic Esters | PURDUE RESEARCH FOUNDATION (US) | 2020-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200079799-A1 | Novel Chiral Alfa-Amino Tertiary Boronic Esters | HBB, BCAT1, BCAT2 | ALDH1A1 3257/4885KMT2A 4542/4885HTT 3285/4885 |
| US-10738064-B2 | Chiral α-amino tertiary boronic esters | HBB, BCAT1, BCAT2 | ALDH1A1 3278/4885KMT2A 4098/4885HTT 2303/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.